Dipeptide prodrug approach to evade efflux pumps and CYP3A4 metabolism of lopinavir.

about

Drug transporters in tissues and cells relevant to sexual transmission of HIV: Implications for drug delivery Prodrug approach to improve absorption of prednisolone

P2860

Q28081272-AFD8E8D6-D0B2-4493-9F7B-4C3D97527162 Q35950189-3A63D6D4-E41B-406D-BCBD-477AD04A5C2D

P2860

Dipeptide prodrug approach to evade efflux pumps and CYP3A4 metabolism of lopinavir.

Item

http://www.wikidata.org/entity/Q43168123

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Dipeptide prodrug approach to evade efflux pumps and CYP3A4 metabolism of lopinavir.

@en

Dipeptide prodrug approach to evade efflux pumps and CYP3A4 metabolism of lopinavir.

@nl

type

Item

label

Dipeptide prodrug approach to evade efflux pumps and CYP3A4 metabolism of lopinavir.

@en

Dipeptide prodrug approach to evade efflux pumps and CYP3A4 metabolism of lopinavir.

@nl

prefLabel

Dipeptide prodrug approach to evade efflux pumps and CYP3A4 metabolism of lopinavir.

@en

Dipeptide prodrug approach to evade efflux pumps and CYP3A4 metabolism of lopinavir.

@nl

P1476

Dipeptide prodrug approach to evade efflux pumps and CYP3A4 metabolism of lopinavir.

@en

P2093

Ashim K Mitra

http://www.w3.org/2001/XMLSchema#string

Dhananjay Pal

http://www.w3.org/2001/XMLSchema#string

Mitesh Patel

http://www.w3.org/2001/XMLSchema#string

Nanda K Mandava

http://www.w3.org/2001/XMLSchema#string

Ye Sheng

http://www.w3.org/2001/XMLSchema#string

P2860

Interaction of gatifloxacin with efflux transporters: a possible mechanism for drug resistance

Vitreal pharmacokinetics of peptide-transporter-targeted prodrugs of ganciclovir in conscious animals.

Intestinal absorption of novel-dipeptide prodrugs of saquinavir in rats.

Both P-gp and MRP2 mediate transport of Lopinavir, a protease inhibitor

Differential effect of P-gp and MRP2 on cellular translocation of gemifloxacin

Membrane transporter/receptor-targeted prodrug design: strategies for human and veterinary drug development.

Functional characterization of peptide transporters in MDCKII-MDR1 cell line as a model for oral absorption studies

Expression and function of efflux drug transporters in the intestine.

Recent patents and emerging therapeutics for HIV infections: a focus on protease inhibitors.

Molecular expression and functional activity of sodium dependent multivitamin transporter in human prostate cancer cells.

P304

99-107

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IJPHARM.2014.09.035

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

476

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25261710

http://www.w3.org/2001/XMLSchema#string

P932

4344907

http://www.w3.org/2001/XMLSchema#string

Dipeptide prodrug approach to evade efflux pumps and CYP3A4 metabolism of lopinavir.

about

P2860

P2860

Dipeptide prodrug approach to evade efflux pumps and CYP3A4 metabolism of lopinavir.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932